Search results
Jump to navigation
Jump to search
Page title matches
- ...links&id=15655528 | doi=10.1038/sj.bjp.0706048 | pmc=PMC1576008 }}</ref> [[Adrenergic beta-antagonist]]s that are selective for the beta-1 [[adrenergic receptor]] may be better ...inase 2 (GRK2) [[genetic polymorphism]]s may also affect the response to [[adrenergic beta-antagonist]]s.<ref>{{OMIM|109635}}</ref>36 KB (4,786 words) - 23:10, 12 October 2011
- #Redirect [[Adrenergic beta-antagonist]]40 bytes (3 words) - 16:06, 6 May 2008
- #Redirect [[Adrenergic beta-antagonist]]40 bytes (3 words) - 16:07, 6 May 2008
- #Redirect [[Adrenergic beta-antagonist]]40 bytes (3 words) - 16:07, 6 May 2008
- #Redirect [[Adrenergic beta-antagonist]]40 bytes (3 words) - 16:07, 6 May 2008
- 349 bytes (40 words) - 16:41, 14 May 2010
- 170 bytes (19 words) - 06:58, 17 October 2010
Page text matches
- adrenergic beta-antagonist [r]: Drugs {{r|adrenergic beta-antagonist}}300 bytes (32 words) - 13:45, 4 July 2009
- {{main|Adrenergic beta-antagonist}}1 KB (159 words) - 04:09, 30 September 2009
- {{r|Adrenergic beta-antagonist}}307 bytes (32 words) - 06:55, 17 October 2010
- #Redirect [[Adrenergic beta-antagonist]]40 bytes (3 words) - 16:07, 6 May 2008
- #Redirect [[Adrenergic beta-antagonist]]40 bytes (3 words) - 16:07, 6 May 2008
- #REDIRECT [[Adrenergic beta-antagonist]]40 bytes (3 words) - 14:37, 4 January 2011
- #Redirect [[Adrenergic beta-antagonist]]40 bytes (3 words) - 16:07, 6 May 2008
- #REDIRECT [[Adrenergic beta-antagonist]]40 bytes (3 words) - 10:12, 14 April 2008
- #REDIRECT [[Adrenergic beta-antagonist]]40 bytes (3 words) - 10:12, 14 April 2008
- #REDIRECT [[Adrenergic beta-antagonist]]40 bytes (3 words) - 10:42, 28 June 2008
- #REDIRECT [[Adrenergic beta-antagonist]]40 bytes (3 words) - 10:12, 14 April 2008
- #REDIRECT [[Adrenergic beta-antagonist]]40 bytes (3 words) - 10:10, 14 April 2008
- #REDIRECT [[Adrenergic beta-antagonist]]40 bytes (3 words) - 17:26, 14 April 2008
- #REDIRECT [[Adrenergic beta-antagonist]]40 bytes (3 words) - 17:26, 14 April 2008
- #Redirect [[Adrenergic beta-antagonist]]40 bytes (3 words) - 16:06, 6 May 2008
- ...line]], are used to treat [[asthma]] by preventing bronchoconstriction. [[Adrenergic beta-antagonist]]s, such as [[atenolol]] or [[metoprolol]] are used to treat cardiac diseas1 KB (147 words) - 06:58, 14 September 2013
- A cardioselective [[adrenergic beta-antagonist]] medication for [[hypertension]] and [[angina pectoris]].141 bytes (13 words) - 10:15, 21 June 2009
- An [[adrenergic beta-antagonist]] useful in [[angina pectoris]], [[hypertension]], or cardiac [[arrhythmias146 bytes (14 words) - 13:31, 4 July 2009
- {{r|Adrenergic beta-antagonist}}638 bytes (62 words) - 07:54, 17 October 2010
- {{r|Adrenergic beta-antagonist}}845 bytes (125 words) - 06:48, 17 October 2010
- *{{r|Adrenergic beta-antagonist|<math>\beta</math>-blocker}}337 bytes (41 words) - 09:07, 19 September 2009
- {{r|adrenergic beta-antagonist}}247 bytes (29 words) - 15:02, 4 July 2009
- {{r|Adrenergic beta-antagonist}}553 bytes (67 words) - 19:16, 11 January 2010
- {{r|adrenergic beta-antagonist}}265 bytes (29 words) - 14:10, 4 July 2009
- |uses=adrenergic beta-antagonist In [[medicine]], '''bisoprolol''' is a "cardioselective [[adrenergic beta-antagonist|beta-1-adrenergic blocker]]. It is effective in the management of [[hyperte2 KB (313 words) - 14:09, 4 July 2009
- {{r|Adrenergic beta-antagonist}}1 KB (165 words) - 08:37, 18 June 2008
- In [[medicine]], '''propranolol''' is "a widely used non-cardioselective [[adrenergic beta-antagonist|beta-adrenergic antagonist]]. Propranolol has been used for [[myocardial in2 KB (236 words) - 14:07, 2 February 2023
- ...he treatment of [[heart failure]], there is conflicting evidence whether [[adrenergic beta-antagonist]]s are as effective in African-American patients as in Anglo patients.<ref ...inase 2 (GRK2) [[genetic polymorphism]]s may also affect the response to [[adrenergic beta-antagonist]]s.<ref>{{OMIM|109635}}</ref>5 KB (679 words) - 09:15, 29 August 2009
- {{r|Adrenergic beta-antagonist}}581 bytes (74 words) - 07:42, 8 January 2010
- The pharmacogenetics of [[adrenergic beta-antagonist]] medications have been reviewed.<ref name="pmid17542770">{{cite journal |a [[Genetic polymorphism]]s of beta-1 (ADRB1) may affect the response to [[adrenergic beta-antagonist]] treatment of [[heart failure]].<ref>{{OMIM|109630}}</ref>6 KB (767 words) - 17:34, 10 February 2024
- {{r|Adrenergic beta-antagonist}}631 bytes (80 words) - 17:07, 11 January 2010
- ...d [[atenolol]], are used to treat [[hypertension]] and tachyarrythmias. [[Adrenergic beta-antagonist]]s that are selective for the beta-1 adrenergic receptor may be better for [[Genetic polymorphism]]s of the beta-1 receptor may affect responses to [[adrenergic beta-antagonist]]s in the treatment of heart failure<ref>{{OMIM|109630}}</ref> and in preve12 KB (1,491 words) - 23:11, 12 October 2011
- {{r|Adrenergic beta-antagonist}}641 bytes (79 words) - 16:44, 11 January 2010
- {{r|Adrenergic beta-antagonist}}2 KB (187 words) - 17:07, 11 January 2010
- {{r|Adrenergic beta-antagonist}}926 bytes (114 words) - 15:48, 11 January 2010
- {{r|Adrenergic beta-antagonist}}1,006 bytes (130 words) - 10:50, 11 January 2010
- {{r|Adrenergic beta-antagonist}}1 KB (134 words) - 15:37, 2 March 2010
- ...ylation of many drugs and environmental chemicals, such as debrisoquine; [[Adrenergic beta-antagonist|adrenergic receptor antagonist]]s; and [[tricyclic antidepressant]]s. This3 KB (483 words) - 17:34, 10 February 2024
- |properties= adrenergic beta-antagonist In [[medicine]], '''metoprolol''' is a [[adrenergic beta-antagonist]] [[medication]] that is a "selective adrenergic beta-1-blocking agent with7 KB (1,032 words) - 13:16, 2 February 2023
- ...sup> [[randomized controlled trial]]s of perioperative<sup>'''†'''</sup> [[Adrenergic beta-antagonist|beta-blockers]].<ref name="pmid19474688">{{cite journal |author=Dunkelgrun <nowiki>†</nowiki> This table does not include trials that used [[Adrenergic beta-antagonist|beta-blockers]] only for [[premedication]] or only during [[postoperative c21 KB (2,642 words) - 17:32, 10 February 2024
- {{r|Adrenergic beta-antagonist}}3 KB (366 words) - 12:22, 18 April 2024
- In [[medicine]], '''atenolol''' is a cardioselective [[adrenergic beta-antagonist]] that is "possessing properties and potency similar to [[propranolol]], bu ...links&id=18612201 | doi=10.1159/000143389 }} </ref> be better than other [[adrenergic beta-antagonist]]s.16 KB (2,243 words) - 11:52, 2 February 2023
- If the patient is taking a [[Adrenergic beta-antagonist|beta-blocker]], reversing its effect with [[glucagon]] may help if the pati12 KB (1,718 words) - 14:14, 21 June 2014
- [[Adrenergic beta-antagonist]]s may be less effective according to [[meta-analysis|meta-analyses]]<ref n4 KB (610 words) - 23:42, 24 May 2012
- ...links&id=15655528 | doi=10.1038/sj.bjp.0706048 | pmc=PMC1576008 }}</ref> [[Adrenergic beta-antagonist]]s that are selective for the beta-1 [[adrenergic receptor]] may be better ...inase 2 (GRK2) [[genetic polymorphism]]s may also affect the response to [[adrenergic beta-antagonist]]s.<ref>{{OMIM|109635}}</ref>36 KB (4,786 words) - 23:10, 12 October 2011
- [[Randomized controlled trial]]s have found benefit from [[adrenergic beta-antagonist]]s such as [[atenolol]]<ref name="pmid2863754">{{cite journal |author=Kraus A case report shows that [[adrenergic beta-antagonist]]s may remove signs of hyperactivity of the [[sympathetic nervous system]]20 KB (2,755 words) - 01:35, 14 September 2013
- Placebo is as effective as adding the [[adrenergic beta-antagonist]] drug [[propanolol]] to patients not adequately controlled on [[topiramate26 KB (3,466 words) - 20:38, 20 March 2014
- One small study found that while the [[adrenergic beta-antagonist]], [[lisinopril]], lowered resting blood pressure, patients with pets and l9 KB (1,385 words) - 08:49, 30 June 2023
- ...ine]]s of the American College of Cardiology/American Heart Association, [[adrenergic beta-antagonist]]s (beta-blockers, "should begin within a few days of the event, if not ini22 KB (2,922 words) - 09:45, 21 February 2015
- *[[Adrenergic beta-antagonist|ß-blockers]] ...(LVH). Based on these two trials, a [[meta-analysis]] has concluded that [[adrenergic beta-antagonist|beta blockers]] should not be the first choice treatment.<ref name="pmid16256 KB (7,418 words) - 15:13, 5 November 2013